Replimune Group Inc (REPL)
6.54
+0.08
(+1.24%)
USD |
NASDAQ |
May 02, 15:45
Replimune Group Price: 6.54 for May 2, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 01, 2024 | 6.36 | 6.76 | 6.22 | 6.46 | 515911.0 |
Apr 30, 2024 | 6.49 | 6.62 | 6.35 | 6.35 | 779090.0 |
Apr 29, 2024 | 6.46 | 6.78 | 6.29 | 6.58 | 480317.0 |
Apr 26, 2024 | 6.22 | 6.575 | 6.06 | 6.42 | 603791.0 |
Apr 25, 2024 | 6.18 | 6.41 | 5.86 | 6.15 | 783453.0 |
Apr 24, 2024 | 6.41 | 6.66 | 6.20 | 6.33 | 631812.0 |
Apr 23, 2024 | 6.47 | 6.77 | 6.385 | 6.42 | 1.157M |
Apr 22, 2024 | 6.56 | 6.669 | 6.22 | 6.42 | 551481.0 |
Apr 19, 2024 | 6.90 | 7.07 | 6.33 | 6.45 | 866786.0 |
Apr 18, 2024 | 7.20 | 7.43 | 6.95 | 6.97 | 1.126M |
Apr 17, 2024 | 7.19 | 7.33 | 7.14 | 7.21 | 1.138M |
Apr 16, 2024 | 7.01 | 7.25 | 6.92 | 7.15 | 684229.0 |
Apr 15, 2024 | 7.14 | 7.26 | 7.07 | 7.12 | 671857.0 |
Apr 12, 2024 | 7.17 | 7.29 | 6.97 | 7.14 | 917240.0 |
Apr 11, 2024 | 7.07 | 7.31 | 6.82 | 7.19 | 710041.0 |
Apr 10, 2024 | 7.01 | 7.03 | 6.72 | 6.96 | 913825.0 |
Apr 09, 2024 | 7.09 | 7.34 | 7.085 | 7.28 | 708204.0 |
Apr 08, 2024 | 7.43 | 7.45 | 7.12 | 7.12 | 574896.0 |
Apr 05, 2024 | 7.47 | 7.72 | 7.095 | 7.36 | 821247.0 |
Apr 04, 2024 | 7.11 | 7.47 | 7.11 | 7.34 | 885555.0 |
Apr 03, 2024 | 7.05 | 7.17 | 6.90 | 7.06 | 1.008M |
Apr 02, 2024 | 7.49 | 7.66 | 7.11 | 7.13 | 953300.0 |
Apr 01, 2024 | 8.17 | 8.17 | 7.67 | 7.73 | 945367.0 |
Mar 28, 2024 | 8.23 | 8.46 | 8.04 | 8.17 | 1.099M |
Mar 27, 2024 | 7.80 | 8.25 | 7.65 | 8.25 | 1.052M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
6.15
Minimum
Apr 25 2024
52.65
Maximum
Dec 01 2020
21.36
Average
19.20
Median
May 13 2020
Price Benchmarks
Esperion Therapeutics Inc | 2.065 |
Gossamer Bio Inc | 0.7613 |
NovaBay Pharmaceuticals Inc | 0.0891 |
Palatin Technologies Inc | 2.01 |
iBio Inc | 2.02 |
Price Related Metrics
Price to Book Value | 0.9525 |
Earnings Yield | -48.32% |
Market Cap | 401.48M |